Cargando…
Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB
This study demonstrates that CDKL3 regulates Akt activation and its downstream targets to promote OS progression, creating a therapeutically targetable vulnerability in treatment of OS.
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Life Science Alliance LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603691/ https://www.ncbi.nlm.nih.gov/pubmed/36270774 http://dx.doi.org/10.26508/lsa.202201656 |
| _version_ | 1784817619390431232 |
|---|---|
| author | He, Aina Ma, Lanjing Huang, Yujing Zhang, Haijiao Duan, Wei Li, Zexu Fei, Teng Yuan, Junqing Wu, Hao Liu, Liguo Bai, Yueqing Dai, Wentao Wang, Yonggang Li, Hongtao Sun, Yong Wang, Yaling Wang, Chunyan Yuan, Ting Yang, Qingcheng Tian, Songhai Dong, Min Sheng, Ren Xiang, Dongxi |
| author_facet | He, Aina Ma, Lanjing Huang, Yujing Zhang, Haijiao Duan, Wei Li, Zexu Fei, Teng Yuan, Junqing Wu, Hao Liu, Liguo Bai, Yueqing Dai, Wentao Wang, Yonggang Li, Hongtao Sun, Yong Wang, Yaling Wang, Chunyan Yuan, Ting Yang, Qingcheng Tian, Songhai Dong, Min Sheng, Ren Xiang, Dongxi |
| author_sort | He, Aina |
| collection | PubMed |
| description | This study demonstrates that CDKL3 regulates Akt activation and its downstream targets to promote OS progression, creating a therapeutically targetable vulnerability in treatment of OS. |
| format | Online Article Text |
| id | pubmed-9603691 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Life Science Alliance LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96036912022-10-27 Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB He, Aina Ma, Lanjing Huang, Yujing Zhang, Haijiao Duan, Wei Li, Zexu Fei, Teng Yuan, Junqing Wu, Hao Liu, Liguo Bai, Yueqing Dai, Wentao Wang, Yonggang Li, Hongtao Sun, Yong Wang, Yaling Wang, Chunyan Yuan, Ting Yang, Qingcheng Tian, Songhai Dong, Min Sheng, Ren Xiang, Dongxi Life Sci Alliance Corrections This study demonstrates that CDKL3 regulates Akt activation and its downstream targets to promote OS progression, creating a therapeutically targetable vulnerability in treatment of OS. Life Science Alliance LLC 2022-10-21 /pmc/articles/PMC9603691/ /pubmed/36270774 http://dx.doi.org/10.26508/lsa.202201656 Text en © 2022 He et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Corrections He, Aina Ma, Lanjing Huang, Yujing Zhang, Haijiao Duan, Wei Li, Zexu Fei, Teng Yuan, Junqing Wu, Hao Liu, Liguo Bai, Yueqing Dai, Wentao Wang, Yonggang Li, Hongtao Sun, Yong Wang, Yaling Wang, Chunyan Yuan, Ting Yang, Qingcheng Tian, Songhai Dong, Min Sheng, Ren Xiang, Dongxi Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB |
| title | Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB |
| title_full | Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB |
| title_fullStr | Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB |
| title_full_unstemmed | Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB |
| title_short | Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB |
| title_sort | correction: cdkl3 promotes osteosarcoma progression by activating akt/pkb |
| topic | Corrections |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603691/ https://www.ncbi.nlm.nih.gov/pubmed/36270774 http://dx.doi.org/10.26508/lsa.202201656 |
| work_keys_str_mv | AT heaina correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT malanjing correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT huangyujing correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT zhanghaijiao correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT duanwei correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT lizexu correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT feiteng correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT yuanjunqing correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT wuhao correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT liuliguo correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT baiyueqing correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT daiwentao correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT wangyonggang correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT lihongtao correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT sunyong correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT wangyaling correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT wangchunyan correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT yuanting correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT yangqingcheng correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT tiansonghai correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT dongmin correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT shengren correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb AT xiangdongxi correctioncdkl3promotesosteosarcomaprogressionbyactivatingaktpkb |